from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1436/gap

LFCtreatmentdescriptionclass of inhibitor

-0.876

Amikacinug/mL Amikacintranslation

-1.788

Cap5-10ug/mL Capreomycintranslation

-0.694

Rox10-50 ug/mL Roxithromycintranslation

0.726

SM2-5 ug/mL Streptomycintranslation

-1.387

Tet5-10 ug/mL Tetracyclinetranslation

-1.638

Rif0.2-5ug/mL Rifampicintranscription

-2.062

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.182

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.408

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.709

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.145

Clofazimine10-13 ug/mL Clofaziminerespiration

0.403

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.803

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.298

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.254

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.039

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.135

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.131

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.486

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.002

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.651

KCN5-20 ug/mL Potassium cyaniderespiration

1.024

NaN30.2-2 mM Sodium aziderespiration

0.753

Nigericin50 uM Nigericinrespiration

-0.785

TRC10-150 ug/mL Triclosanrespiration

-1.228

TRZ10-25 ug/mL Thioridazinerespiration

-0.866

Valinomycin0.5-10 uM Valinomycinrespiration

0.591

ZnSO42 mM ZnSO4respiration

0.268

menadione6-10 ug/mL Menadionerespiration

-0.420

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.273

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.161

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.667

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.084

NRP_1Non-replicating persistence stage 1dosRassociated

0.980

Amp0.2mg/mL AmpicillincellWall

0.555

Cephalexin20-100 ug/mL CephalexincellWall

0.040

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.247

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.328

EMB10-20 ug/mL EthambutolcellWall

0.752

Eta12-40 ug/mL EthionamidecellWall

0.501

INH0.2-0.4 ug/mL IsoniazidcellWall

0.669

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.525

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.616

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.700

BZA0.12 mg/mL BenzamidearomaticAmides

0.239

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.635

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.536

H2O24 mM hydrogen peroxideDNAdamaging

-1.317

Levo10 ug/mL LevofloxacinDNAdamaging

0.705

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.108

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.489

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.300

UVUV-irradiationDNAdamaging

-1.578

ARP41-4 ug/mL Antitubercular compound ARP4?

0.267

Antimycin12.5-50 ug/mL Antimycin A?

0.498

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.606

PA_110-50 ug/mL Antitubercular compound PA-1?

0.540

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.451

PA8240.2-2 ug/mL PA-824?

0.234

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.407

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.137

Verapamil50 uM Verapamil?

0.307

mercaptoethanol2 mM 2-Mercaptoethanol?

0.150

methoxatin10-20 ug/mL Methoxatin?